Podchaser Logo
Home
Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Released Monday, 7th March 2022
Good episode? Give it some love!
Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Monday, 7th March 2022
Good episode? Give it some love!
Rate Episode

In this episode presented by the Canadian Heart Failure Society (CHFS) entitled “Recommendations for Initiation of SGLT2i in Patients with HF and T2D” presented by Dr. Grace Chua, we will focus on the initiation of SGLT2i in patients with HFrEF and Type 2 Diabetes and we will review practical tips and key questions to a patient case. An on-demand version of the 30-minute episode presented on the same topic is available right now at www.imedicus.ca/hf21. To learn more about the Canadian Heart Failure Society and find out more about upcoming programs and initiatives, visit www.heartfailure.ca. We hope you enjoy this episode! 

This program was made possible through grants from Novartis and BI-Lilly Alliance. 

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features